“We are completely agnostic to what sort of technology we adopt but given the relationship between the UAE, specifically Abu Dhabi and the US, the decision was made to continue working and ...

The Target-MRD blood test uses a combination of tumor-informed and tumor-agnostic molecular features for personalized, accurate and more effective monitoring of molecular residual disease.